• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells.

作者信息

Hollingdale M R, Ballou W R, Aley S B, Young J F, Pancake S, Miller L H, Hockmeyer W T

出版信息

Exp Parasitol. 1987 Jun;63(3):345-51. doi: 10.1016/0014-4894(87)90182-2.

DOI:10.1016/0014-4894(87)90182-2
PMID:2438152
Abstract

The immunodominant epitope region of the circumsporozoite protein of Plasmodium falciparum sporozoites contains 37 tandem repeats of the tetrapeptide Asn-Ala-Asn-Pro and 4 repeats of Asn-Val-Asp-Pro. Synthetic peptides and recombinant proteins of the repeat region were used to immunize mice using different doses and adjuvants. Antisera were tested for inhibition of sporozoite invasion of cultured human hepatoma cells. Synthetic peptides and recombinant proteins elicited high levels of antibodies that inhibited sporozoite invasion when emulsified with complete Freund's adjuvant. Since recombinant proteins with alum elicited a better antibody response to sporozoite invasion than they did without adjuvant, it may be that a recombinant protein containing 32 tandem copies of the tetrapeptide repeat combined with alum could be a candidate malarial vaccine suitable for human trials.

摘要

相似文献

1
Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells.
Exp Parasitol. 1987 Jun;63(3):345-51. doi: 10.1016/0014-4894(87)90182-2.
2
Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro.抗重组和合成肽抗体对恶性疟原虫子孢子的体外作用。
Science. 1986 Jan 10;231(4734):156-9. doi: 10.1126/science.3510455.
3
Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli.恶性疟原虫:大肠杆菌中产生的环子孢子蛋白构建体的免疫原性
Exp Parasitol. 1987 Apr;63(2):166-72. doi: 10.1016/0014-4894(87)90158-5.
4
Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.对疟疾的免疫力以及对恶性疟原虫环子孢子蛋白的自然获得性抗体。
N Engl J Med. 1986 Sep 4;315(10):601-6. doi: 10.1056/NEJM198609043151001.
5
A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.恶性疟原虫环子孢子蛋白的保守肽序列及抗肽抗体可抑制伯氏疟原虫子孢子对Hep-G2细胞的侵袭,并保护免疫小鼠免受伯氏疟原虫子孢子攻击。
Infect Immun. 1995 Nov;63(11):4375-81. doi: 10.1128/iai.63.11.4375-4381.1995.
6
Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2.
Vaccine. 1996 Jan;14(1):77-84. doi: 10.1016/0264-410x(95)00149-u.
7
Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.恶性疟原虫环子孢子蛋白非重复序列在人和小鼠中的免疫原性。
Immunology. 1988 Feb;63(2):187-91.
8
Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.恶性疟原虫环子孢子蛋白合成肽的免疫原性。
Science. 1985 May 24;228(4702):996-9. doi: 10.1126/science.2988126.
9
Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application.基于恶性疟原虫环子孢子蛋白B细胞和T细胞表位的明矾吸附合成多抗原肽的免疫原性:可能的疫苗应用
Vaccine. 1994 Aug;12(11):1012-7. doi: 10.1016/0264-410x(94)90337-9.
10
Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.在卡介苗致敏小鼠中使用结核菌素纯化蛋白衍生物——天冬酰胺-丙氨酸-天冬酰胺-脯氨酸缀合物可克服抗体反应的H-2限制,且无需佐剂。
Proc Natl Acad Sci U S A. 1990 Apr;87(8):2960-4. doi: 10.1073/pnas.87.8.2960.

引用本文的文献

1
Current view on novel vaccine technologies to combat human infectious diseases.当前对抗人类传染病新型疫苗技术的看法。
Appl Microbiol Biotechnol. 2022 Jan;106(1):25-56. doi: 10.1007/s00253-021-11713-0. Epub 2021 Dec 10.
2
Circumsporozoite Surface Protein-based malaria vaccines: a review.基于环子孢子表面蛋白的疟疾疫苗:综述。
Rev Inst Med Trop Sao Paulo. 2021 Jan 29;63:e11. doi: 10.1590/S1678-9946202163011. eCollection 2021.
3
A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.
一种全面评估针对间日疟原虫和恶性疟原虫肝期治疗的模型。
Nat Commun. 2018 May 9;9(1):1837. doi: 10.1038/s41467-018-04221-9.
4
Malaria vaccines: identifying Plasmodium falciparum liver-stage targets.疟疾疫苗:确定恶性疟原虫肝脏期靶点。
Front Microbiol. 2015 Sep 15;6:965. doi: 10.3389/fmicb.2015.00965. eCollection 2015.
5
Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.伯氏疟原虫肝期特异性CD8 + T细胞体外检测方法的建立及其对肝期抑制作用的验证
PLoS One. 2015 Mar 30;10(3):e0119880. doi: 10.1371/journal.pone.0119880. eCollection 2015.
6
Malaria vaccines.疟疾疫苗
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1167-9. doi: 10.1073/pnas.96.4.1167.